These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15316836)

  • 1. QT-interval parameters in end-stage renal disease--is cardiovascular autonomic neuropathy unimportant?
    Cardoso C; Salles G
    Clin Auton Res; 2004 Aug; 14(4):214-6. PubMed ID: 15316836
    [No Abstract]   [Full Text] [Related]  

  • 2. Autonomic neuropathy and QT interval in hemodialysed patients.
    Maule S; Veglio M; Mecca F; Calvo C; Martina G; Marangella M; Quadri R; Cavallo Perin P
    Clin Auton Res; 2004 Aug; 14(4):233-9. PubMed ID: 15316840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease.
    Mohamed R; Forsey PR; Davies MK; Neuberger JM
    Hepatology; 1996 May; 23(5):1128-34. PubMed ID: 8621144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac electrophysiological abnormalities in patients with cirrhosis.
    Zambruni A; Trevisani F; Caraceni P; Bernardi M
    J Hepatol; 2006 May; 44(5):994-1002. PubMed ID: 16510203
    [No Abstract]   [Full Text] [Related]  

  • 5. Dysfunction of the autonomic nervous system in patients with end-stage renal failure.
    Zucchelli P; Sturani A; Zuccalà A; Santoro A; Degli Esposti E; Chiarini C
    Contrib Nephrol; 1985; 45():69-81. PubMed ID: 3979055
    [No Abstract]   [Full Text] [Related]  

  • 6. Autonomic and peripheral neuropathy in primary biliary cirrhosis: evidence of small sensory fibre damage and prolongation of the QT interval.
    Kempler P; Váradi A; Kádar E; Szalay F
    J Hepatol; 1994 Dec; 21(6):1150-1. PubMed ID: 7699249
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac autonomic neuropathy and QT interval length. A follow-up study in diabetic patients.
    Jermendy G; Tóth L; Vörös P; Koltai MZ; Pogátsa G
    Acta Cardiol; 1991; 46(2):189-200. PubMed ID: 2048366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corrected QT interval and diabetic neuropathy of the cardiovascular system].
    Klupa T; Mroczek T; Galicka-Latała D; Kozek E; Sieradzki J
    Przegl Lek; 1995; 52(12):583-7. PubMed ID: 8834655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodialysis increases QTc interval but not QTc dispersion in ESRD patients without manifest cardiac disease.
    Ljutic D
    Nephrol Dial Transplant; 2003 Jul; 18(7):1414; author reply 1414. PubMed ID: 12808189
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged QTc intervals in Parkinson's disease--relation to sudden death and autonomic dysfunction].
    Ishizaki F; Harada T; Yoshinaga H; Nakayama T; Yamamura Y; Nakamura S
    No To Shinkei; 1996 May; 48(5):443-8. PubMed ID: 8672303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of the measurement of corrected QT (QTc) for the diagnosis of diabetic neuropathy of the autonomic cardiovascular system].
    Wierusz-Wysocka B; Sadurska K; Lukomska E; Dmochowska H
    Pol Tyg Lek; 1992 Jun 1-8; 47(22-23):478-9. PubMed ID: 1437772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of the QTc-interval reflects the severity of autonomic neuropathy in primary biliary cirrhosis and in other non-alcoholic liver diseases.
    Kempler P; Szalay F; Váradi A; Keresztes K; Kádár E; Tánczos E; Petrik J
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():96-8. PubMed ID: 7483730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical utility of QT interval assessment in diabetes.
    Veglio M; Chinaglia A; Cavallo Perin P
    Diabetes Nutr Metab; 2000 Dec; 13(6):356-65. PubMed ID: 11232762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors related to the QT prolongation in chronic renal failure].
    Kurosu M; Ando Y; Akimoto T; Ono S; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 1999 Apr; 41(2):70-6. PubMed ID: 10361422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of methods for assessing baroreflex sensitivity and temporal QT variability in end-stage renal disease and healthy subjects.
    Gao SA; Johansson M; Hammarén A; Nordberg M; Friberg P
    Clin Auton Res; 2005 Feb; 15(1):21-8. PubMed ID: 15768198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of autonomic nervous system dysfunction in uremia.
    Campese VM; Romoff MS; Levitan D; Lane K; Massry SG
    Kidney Int; 1981 Aug; 20(2):246-53. PubMed ID: 7026874
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.
    Pappachan JM; Sebastian J; Bino BC; Jayaprakash K; Vijayakumar K; Sujathan P; Adinegara LA
    Postgrad Med J; 2008 Apr; 84(990):205-10. PubMed ID: 18424578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT interval prolongation and ventricular fibrillation in childhood end-stage renal disease.
    Kim GB; Cho HY; Kwon BS; Bae EJ; Noh CI; Choi JY; Yun YS; Choi Y; Ha JW
    Int J Cardiol; 2008 Jul; 127(3):e126-8. PubMed ID: 17714808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic nervous system dysfunction in chronic uraemics on haemodialysis.
    Vita G; Dattola R; Puglisi RM; Marabello L; Venuto C; Toscano A; Savica V; Bellinghieri G; Messina C
    Funct Neurol; 1989; 4(2):195-7. PubMed ID: 2737511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.